Top Markets
Coin of the day
ProUroCare Medical Inc. ProUroCare Medical Inc.

ProUroCare Medical Inc.

PUMD
Classement en actions #42361
ProUroCare Medical Inc. is dedicated to developing advanced products for the... ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$1.86K
Changement (1 jour)
0.00%
Changement (1 an)
-50.00%
Pays
US
Échange ProUroCare Medical Inc. (PUMD)

Catégorie

EPS pour ProUroCare Medical Inc. (PUMD)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de ProUroCare Medical Inc., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de ProUroCare Medical Inc. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$3.11 -
US
$9.73 -
US
$3.59 -
IE
$2.48 -
US
$1.74 -
US